MaxCyte's average Accounts Receivable for the
three
months ended in Mar. 2024 was $5.88 Mil. MaxCyte's Revenue for the
three
months ended in Mar. 2024 was $11.34 Mil.
Hence, MaxCyte's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 47.34.
The historical rank and industry rank for MaxCyte's Days Sales Outstanding or its related term are showing as below:
MXCT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.85 Med: 67.43 Max: 86.75
Current: 61.78
During the past 12 years, MaxCyte's highest Days Sales Outstanding was 86.75. The lowest was 53.85. And the median was 67.43.
MXCT's Days Sales Outstanding is ranked better than 52.59% of 812
companies
in the Medical Devices & Instruments industry
Industry Median: 64.77
vs MXCT: 61.78
MaxCyte's Days Sales Outstanding
declined
from Mar. 2023 (119.05) to Mar. 2024 (47.34).
MaxCyte Days Sales Outstanding Historical Data
The historical data trend for MaxCyte's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of MaxCyte's Days Sales Outstanding
For the Medical Devices subindustry, MaxCyte's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MaxCyte's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MaxCyte's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where MaxCyte's Days Sales Outstanding falls into.
MaxCyte Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MaxCyte (NAS:MXCT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
MaxCyte Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of MaxCyte's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MXCT has been successfully added to your 